SmartBio Analytics recognized with the 2026 Business Innovation Award
We are proud to announce that SmartBio Analytics has received the 2026 Business Innovation Award, presented by the Asociación de Empresas de Tres Cantos (AETC) together with ASECATC.
The award recognizes companies that are making a significant contribution to technological innovation, scientific excellence and economic development within one of Spain’s leading innovation ecosystems.
For our team, this recognition represents much more than an award—it validates our mission of helping pharmaceutical and biotechnology companies accelerate the development of safer and more effective medicines through high-quality LC-MS/MS bioanalysis.
A recognition of innovation in pharmaceutical bioanalysis
Since our foundation, SmartBio Analytics has focused on building a highly specialized bioanalytical CRO capable of delivering fast, reliable and regulatory-compliant analytical services.
Our laboratory supports pharmaceutical companies, biotechnology companies, hospitals, research centres and CROs by providing:
- LC-MS/MS bioanalysis
- Bioanalytical method development
- Bioanalytical method validation
- Pharmacokinetic (PK) studies
- Toxicokinetic (TK) studies
- Biomarker quantification
- Small molecule bioanalysis
- Peptide bioanalysis
- Oligonucleotide bioanalysis
- Clinical and preclinical sample analysis
Explore our Bioanalysis Services
Building strategic bioanalytical capabilities in Spain
One of SmartBio Analytics’ main objectives has always been to strengthen Spain’s scientific and pharmaceutical ecosystem.
Based in Tres Cantos (Madrid), we work with national and international clients developing analytical methods that support every stage of drug development—from discovery and preclinical studies through to clinical trials.
As a GLP-certified laboratory operating under GLP and GCP quality standards, we help generate reliable bioanalytical data required for regulatory submissions and informed decision-making.
Learn more about our GLP Bioanalytical Laboratory
Why innovation matters in bioanalysis
Modern drug development increasingly relies on sophisticated analytical technologies capable of measuring compounds at extremely low concentrations while maintaining exceptional accuracy and reproducibility.
Innovation in bioanalysis means continuously improving:
- LC-MS/MS workflows
- Sample preparation strategies
- Method sensitivity
- Laboratory efficiency
- Data quality
- Turnaround times
- Regulatory compliance
At SmartBio Analytics, innovation is not limited to new technologies—it also means finding smarter ways to deliver faster, more reliable results for our clients.
Learn more about our Method Development and Validation
Supporting the future of pharmaceutical innovation
Receiving this award reinforces our commitment to supporting the pharmaceutical and biotechnology industries through high-quality analytical science.
Every validated method, every pharmacokinetic study and every biomarker analysis ultimately contributes to one common goal: helping innovative therapies reach patients more efficiently.
Whether supporting small molecules, peptides, proteins or oligonucleotides, our mission remains the same: providing robust bioanalytical data that enables better decisions throughout drug development.
Learn more about our expertise in PK Studies and Biomarker Analysis
Thank you
This recognition would not have been possible without the trust of our clients, collaborators and partners.
We would like to thank AETC and ASECATC for this honour, as well as the entire scientific and business community of Tres Cantos, whose collaborative ecosystem continues to drive innovation in life sciences.
Most importantly, we would like to thank every member of the SmartBio Analytics team for their passion, dedication and commitment to scientific excellence.
About SmartBio Analytics
SmartBio Analytics is a GLP-certified bioanalytical CRO based in Madrid, Spain, specializing in LC-MS/MS bioanalysis for pharmaceutical, biotechnology and biomedical research.
Our expertise includes:
- Bioanalytical Method Development
- Bioanalytical Method Validation
- LC-MS/MS Bioanalysis
- Pharmacokinetic Studies
- Toxicokinetic Studies
- Biomarker Analysis
- Small Molecules
- Peptides
- Oligonucleotides
- Clinical Bioanalysis
- Preclinical Bioanalysis
Looking for a trusted bioanalytical partner?
If your organization requires expert support in LC-MS/MS bioanalysis, bioanalytical method development, method validation, PK studies or biomarker analysis, we’d be delighted to discuss your project.